Figure 2.
Clinical photos of core dermatologic immune-related adverse events (D-irAE) diagnoses. (A) ICI-Psoriasis; (B) ICI-Lichen planus; (C) ICI-Bullous pemphigoid; (D) ICI-Vitiligo; (E) ICI-Grovers; (F) ICI-Eczematous dermatitis; (G) ICI-Exanthem; (H) ICI-Eruptive atypical squamous proliferation, (I) ICI-Erosive mucocutaneous. ICI, Immune checkpoint inhibitor.